Profile picture

Doctor Anna Borowiec

National Institute of Oncology, Warsaw, Poland, Warsaw (Poland)
Membership: ESC Professional Member EACVI Member HFA Member
Follow
Logo ESC

Contributor content

Prognostic value of asymptomatic coronary artery disease and coronary artery calcium score for the risk of cancer therapy-related cardiac dysfunction (ANTEC study)
Presentation
Prognostic value of asymptomatic coronary artery disease and coronary artery calcium score for the risk of cancer therapy-related cardiac dysfunction (ANTEC study)
Interleukin-6 as a potential biomarker of cancer therapy-related cardiac dysfunction: A comparative analysis with myeloperoxidase and tumor necrosis factor-alpha.
Presentation
Interleukin-6 as a potential biomarker of cancer therapy-related cardiac dysfunction: A comparative analysis with myeloperoxidase and tumor necrosis factor-alpha.
Predictors of cardiovascular events in patients with primary systemic vasculitis: a 5 years prospective observational study.
Presentation
Predictors of cardiovascular events in patients with primary systemic vasculitis: a 5 years prospective observational study.
Incidence of venous thromboembolism in patients with granulomatosis with polyangiitis (Wegener's granulomatosis).
Presentation
Incidence of venous thromboembolism in patients with granulomatosis with polyangiitis (Wegener's granulomatosis).
Elevated levels of D-dimer are associated with inflammation and disease activity rather than risk of venous thromboembolism in patients with granulomatosis with polyangiitis
Presentation
Elevated levels of D-dimer are associated with inflammation and disease activity rather than risk of venous thromboembolism in patients with granulomatosis with polyangiitis
High risk of venous thromboembolism but not of coronary artery disease in granulomatosis with polyangiitis (Wegener's granulomatosis) in first years after diagnosis.
Presentation
High risk of venous thromboembolism but not of coronary artery disease in granulomatosis with polyangiitis (Wegener's granulomatosis) in first years after diagnosis.
Echocardiographic evaluation in patients with granulomatosis with polyangiitis
Presentation
Echocardiographic evaluation in patients with granulomatosis with polyangiitis

ESC 365 is supported by